Omega-3 is an essential fatty acid (EFA) which provides eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the support of heart and brain health. An inadequate intake of EFAs can result in the development of chronic health problems that can interfere with quality of life. Deficiency in DHA is associated with cognitive decline. The Framingham Heart Study found that men and women who had an average DHA intake of 180 mg/day and an average fish intake of three servings per week had a 47% reduction in the risk of cognitive decline (1). Omega-3 essential fatty acids (EFAs) can also support the cardiovascular system. In a clinical trial in Italy, heart attack patients were given 1000 mg per day of omega-3 EFAs. Within three months of the incidence, the risk of sudden cardiac death was reduced by 45% (2). Other researchers have found that omega-3 EFAs significantly reduced coronary mortality for people with no history of cardiovascular disease (3). Features and Benefits: Source of omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), for the maintenance of good health Helps maintain/support cardiovascular health Helps support cognitive health and/or brain function Helps reduce serum triglycerides/triacylglycerols Softgels are 50% smaller for easier swallowing Softgels contain natural enteric ingredients to prevent fishy burps or aftertaste Contains no artificial colours, preservatives, or sweeteners NPN #80032972 Dosage: Adults: 3 softgels daily or as recommended by a physician. Reduce Triglycerides/Triacylglycerols: 4 softgels daily or as directed by a physician Servings: 90 to 120 days depending on serving choice Cautions or Warnings: Keep out of reach of children Storage: Protect from heat and humidity References: 1. Schaefer E. et al. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease. The Framingham Heart Study. Arch Neurol. 2006;63:1545-1550. 2. Marchioli R, Schweiger C, Tavazzi L. et al. Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. Lipids. 2001;36 Suppl: S119-26. 3. Saremi A, Arora R. The utility of omega-3 fatty acids in cardiovascular disease. Am J Ther. 2008;Dec 15.